Delivery Order SPE2DB24D2205-SPE2DB25FEBBE

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,268.37, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a type of contraceptive patch. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 30, 2024. The contract was awarded on May 29, 2024 and does not have a set-aside designation,...
This federal contract award, valued at $15,075.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a type of prescription contraceptive patch. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 9, 2024. This award is not associated with a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,520.28, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The contract has a completion date of March 12, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $3,162.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xulane 150-35 mcg/day patch, a contraceptive product, and is classified as a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of April 11, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,070.14 firm-fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The contract has an ultimate completion date of November 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,238.60 firm fixed-price contract is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive patch. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor in the United States. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch, under a Firm Fixed Price Delivery Order valued at $6,216.86. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen, through its Corporate Office Division, has been awarded this contract to...
This federal contract award, valued at $4,879.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive product. The contract has a firm fixed price and is a delivery order with an ultimate completion date of July 8, 2022. The contract is not designated with any set-aside requirements, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,137.76 Firm Fixed Price Delivery Order contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a transdermal contraceptive patch. The contract has an ultimate completion date of September 27, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen, the prime...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a transdermal contraceptive patch. The contract has a ceiling value of $32,587.35 and an ultimate completion date of March 13, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBBE
    Delivery Order

This federal contract award, valued at $8,291.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch, with an ultimate completion date of April 17, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract positions Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/16/25, 12:30 PM